INVO FERTILITY INC (IVF) Forecast, Price Target & Analyst Ratings
NASDAQ:IVF • US44984F8077
0.867 USD
-0.02 (-2.21%)
Last: Mar 5, 2026, 10:45 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INVO FERTILITY INC (IVF).
Forecast Snapshot
Consensus Price Target
$4.08
+ 370.59% Upside
Next Earnings Forecast
Release DateApr 28, 2026
PeriodQ4 / 2025
EPS Estimate-$0.56
Revenue Estimate1.946M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$4.08
Upside
+ 370.59%
From current price of $0.87 to mean target of $4.08, Based on 5 analyst forecasts
Low
$4.04
Median
$4.08
High
$4.20
Price Target Revisions
1 Month
-97.22%
3 Months
-77.78%
Price Target Summary
5 analysts have analysed IVF and the average price target is 4.08 USD. This implies a price increase of 370.59% is expected in the next year compared to the current price of 0.867.
The average price target has been revised downward by 77.78% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
IVF was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IVF.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed IVF. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 28, 2026
PeriodQ4 / 2025
EPS Estimate-$0.56
Revenue Estimate1.946M
Revenue Q2Q-61.84%
EPS Q2Q99.91%
Number of Analysts2
Next Earnings Revisions
Revenue (1 Month)
2.21%
Revenue (3 Months)
2.21%
EPS (1 Month)
-1,000.00%
EPS (3 Months)
-1,000.00%
Next Earnings Summary
IVF is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is -0.56 USD and the consensus revenue estimate is 1.95M USD.
The next earnings revenue estimate has been revised upward by 2.21% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 820K -80.29% | 3.021M 268.37% | 6.532M 116.25% | 7.257M 11.10% | 10.523M 45.00% | 16.626M 58.00% | 9.384M -43.56% | 10.322M 10.00% | 11.354M 10.00% | 12.491M 10.01% | 13.739M 9.99% | 15.114M 10.01% | |
| EBITDA YoY % growth | -10.55M -103.28% | -6.566M 37.76% | -6.694M -1.95% | -2.764M 58.70% | -2.3M 16.81% | 276.74K 112.03% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -10.63M -103.64% | -6.767M 36.34% | -7.614M -12.51% | -23.096M -203.34% | -4.645M 79.89% | -2.187M 52.92% | -56.585M -2,487.76% | -57.266M -1.20% | -56.213M 1.84% | -56.656M -0.79% | -57.04M -0.68% | -57.356M -0.55% | |
| Operating Margin | -1,296.34% | -224.03% | -116.56% | -318.25% | -44.14% | -13.15% | -603.00% | -554.80% | -495.09% | -453.57% | -415.17% | -379.49% | |
| EPS YoY % growth | -5,126.40 -32.44% | N/A 99.99% | N/A -92,900.00% | -26.91 92.84% | -23.76 11.71% | -44.60 -87.76% | -5.06 88.65% | -40.97 -709.58% | -37.33 8.88% | -37.33 | -37.57 -0.65% | -36.84 1.94% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.56 99.91% | -0.25 65.28% |
| Revenue Q2Q % growth | 1.946M -61.84% | 2M 22.16% |
| EBITDA Q2Q % growth | -869.61K 65.82% | -870.62K 60.92% |
| EBIT Q2Q % growth | -1.414M 59.18% | -1.41M 42.74% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
23.45%
EPS Next 5 Year
13.59%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
37.40%
Revenue Next 5 Year
10.00%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
27.17%
EBIT Next 5 Year
N/A
INVO FERTILITY INC / IVF Forecast FAQ
What is the average price target for INVO FERTILITY INC (IVF) stock?
5 analysts have analysed IVF and the average price target is 4.08 USD. This implies a price increase of 370.59% is expected in the next year compared to the current price of 0.867.
When does INVO FERTILITY INC (IVF) report earnings?
INVO FERTILITY INC (IVF) will report earnings on 2026-04-28, after the market close.
What are the consensus estimates for INVO FERTILITY INC (IVF) next earnings?
The consensus EPS estimate for the next earnings of INVO FERTILITY INC (IVF) is -0.56 USD and the consensus revenue estimate is 1.95M USD.
Can you provide the consensus rating for INVO FERTILITY INC stock?
The consensus rating for INVO FERTILITY INC (IVF) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.